Mars Has a Lake of Liquid Water: Study

Radar data indicate that the Red Planet’s southern polar ice sheets cover a 20-kilometer-wide body of water.

Jul 25, 2018
Ashley Yeager

Mars may have liquid water—a huge lake nestled under the ice cap at the planet’s southern pole, researchers report today (July 25) in Science. Planetary scientists have debated for decades whether the Red Planet has liquid water, usually discussing the possible presence of small amounts that quickly appear and disappear, but the new discovery suggests Mars has a large, standing reservoir of water.

“This is potentially a really big deal,” planetary scientist Briony Horgan of Purdue University tells Science News. “It’s another type of habitat in which life could be living on Mars today.”

Roberto Orosei of the National Institute of Astrophysics in Bologna, Italy, and his colleagues detected a bright spot at the southern pole using radar data taken with the Mars Express spacecraft from May 2012 to December 2015. The team ruled out that carbon dioxide ice or other features created the spot and were left with one explanation—a lake of liquid water.

“On Earth, nobody would have been surprised to conclude that this was water,” Orosei tells Science News. “But to demonstrate the same on Mars was much more complicated.”

Based on the data, the researchers concluded the water reservoir sits 1.5 kilometers beneath the surface ice at the Martian southern pole and is 20 kilometers wide. Mixed within the water might be salt or mud, which would keep it from freezing. (Temperatures at the bottom of the ice sheet may be as low as –68 °C). Still, that might not prevent life from calling the lake home.

“In this kind of environment that we know of on Earth, in the Antarctic, we have bacteria,” study coauthor Elena Pettinelli of Italy’s Roma Tre University tells National Geographic. “They can be deep in the ice.”

See “Search for Life on the Red Planet

The results still need to be confirmed by other teams. Researchers haven’t detected the same reflective spot with instruments aboard the Mars Reconnaissance Orbiter, notes Nathaniel Putzig of the Planetary Science Institute in a CNN article. He and his colleagues plan to review the data from Mars Express. “I'm excited to see how the 3-D imaging will clarify the view of this detection and whether we will find similar ones elsewhere beneath the polar caps,” he tells CNN.

“There are other areas that seem to be similar,” Pettinelli notes in the National Geographic piece. “There’s no reason to say this is the only one.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb


Sponsored Product Updates

Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to includeex vivoT lymphocytes. The service extension meets the requirements of immunology-based research in drug discovery,enabling new gene targets to be identified in biologically and potentially therapeutically relevant settings.
pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.